Novo Nordisk's pricing procedures in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of value gouging, stating the stark contrast between U.S. charges and people in Europe and copyright. are scheduled to obtain surgical procedure or oth